Treprostinil
Back to searchMolecule Structure
Scientific Name
Treprostinil
Description of the Drug
Treprostinil is a prostacyclin vasodilator for the treatment of pulmonary arterial hypertension to relieve exercise associated symptoms and to prevent clinical deterioration after stopping epoprostenol.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00374
http://www.drugbank.ca/drugs/DB00374
Brand Name(s)
Remodulin, Tyvaso
Company Owner(s)
Sandoz Inc, Teva Pharmaceuticals Usa, Alembic Global Holding Sa, Par Sterile Products Llc, Dr Reddys Laboratories Ltd, United Therapeutics Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Prostanoid IP receptor | SINGLE PROTEIN | AGONIST | CHEMBL1995 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4349618 | ||||
| Human Metabolome Database | HMDB0014518 | ||||
| WDI | U-62840 | ||||
| DrugBank | DB00374 | ||||
| PubChem: Thomson Pharma | 14854155 | 14878554 | |||
| PubChem | 6918140 | ||||
| LINCS | LSM-45331 | ||||
| Nikkaji | J430.982K | ||||
| DrugCentral | 2720 | ||||
| Metabolights | MTBLC50861 | ||||
| ChemicalBook | CB32460050 | ||||
| Guide to Pharmacology | 5820 | ||||
| GSRS | 87c7535e-4133-46ec-9879-bc4c9fee2f82 | ||||
| rxnorm | TREPROSTINIL | ORENITRAM | TYVASO | REMODULIN | TREPROSTINIL DIOLAMINE |
| ChEBI | 50861 | ||||
| ZINC | ZINC000003800475 |
